Search

Home > Angel Invest Boston > Prof. Tom Eisenmann - "Why Startups Fail"
Podcast: Angel Invest Boston
Episode:

Prof. Tom Eisenmann - "Why Startups Fail"
Category: Business
Duration: 00:49:32
Publish Date: 2021-12-08 06:30:00
Description:

Sal's Investment Syndicate: Click to Join

Harvard’s Tom Eisenmann is the author of Why Startups Fail: A New Roadmap for Entrepreneurial Success. We discussed valuable lessons from the book and how they might apply to biotech startups.

Highlights:

  • Sal Daher Introduces Prof. Tom Eisenmann of the Harvard Business School, Author of Why Startups Fail
  • Howard Stevenson’s 400X Return
  • Contrasting Brad Feld’s Book with Prof. Tom Eisenmann’s Book
  • Sal Daher’s Favorite Part of the Book: Failing
  • “[failed] founders probably cycle through those. ...the Kubler Ross stages...”
  • “...basically, half of failed founders come back and get back on the horse and do it again.”
  • Shutting Down the Failed Venture, Gracefully
  • The Number One Killer of Startups: False Starts
  • “...engineers are particularly vulnerable to this because they want to build.”
  • Sal Daher Discusses SQZ Biotech’s False Start and Brilliant Pivot
  • The Origin Story of Why Startups Fail
  • “...the factories that actually make this stuff actually generate enough cash to invest in new apparel companies...”
  • Silver Linings of the Pandemic
  • Tom Eisenmann on Harvard’s School of Engineering and the MS/MBA Program
  • Tom Eisenmann on Tough Tech: Technical Uncertainty + Market Uncertainty
  • Creating Supports for Life Science Academics to Become Founders
  • Creative Destruction Labs
  • Sal Daher’s Focus on Biotech Angel Formation
  • Software Startup Funding vs. Biotech Startup Funding
  • Maybe Successful Angel-Backed Founders Such as Todd Zion and Armon Sharei Could be a Resource for Training Angels
  • The Dynamics of Venture Capital in the Last Decade – Many New Shoots
  • Tom Eisenmann’s Parting Thoughts

Sponsored by:

  • Purdue University entrepreneurship, and
  • Peter Fasse, patent attorney at Fish & Richardson

Topics: biotech, management, co-founders, Mass Challenge, raising money, scholar, venture capital
Total Play: 0

Users also like

100+ Episodes
Aos Cubos 10+     2